Sign in Subscribe
Vaccines

US Government Declines Additional Pfizer Vaccine Doses, Bets on Multiple Vaccine Options

Strategic Insights

— 2 min read

The US government has declined Pfizer's offers for additional batches of its COVID-19 vaccine, citing a bet on multiple vaccine options. Pfizer's board member and former FDA commissioner, Dr. Scott Gottlieb, stated that the company may not be able to offer more shots to the nation until next June. The US has agreements with five or six manufacturers for around 100 million doses, according to Gottlieb. This decision comes as the Trump administration initially rejected an offer from Pfizer in late summer for additional doses of its COVID-19 vaccine.

Key Takeaways:

  • The US government has declined Pfizer's offers for additional batches of its COVID-19 vaccine, opting for multiple vaccine options instead.
  • The government has agreements with five or six manufacturers for around 100 million doses, according to Dr. Scott Gottlieb.
  • Pfizer's board member and former FDA commissioner, Dr. Scott Gottlieb, stated that the company may not be able to offer more shots to the nation until next June.
  • The US initially ordered 100 million doses of Pfizer's vaccine, enough to vaccinate 50 million people, but may need to wait until next June for additional doses.
  • The Pharmaceutical giant offered the government additional doses "multiple times," including as recently as after some initial data results came out in November.
  • The US government has backed six vaccine candidates with multi-billion-dollar deals.
  • The EU has accepted the approval application for Pfizer and BioNTech's vaccine, and will acquire 200 million doses.
  • Pfizer has sealed deals with other governments, including the European Union, and will sell them some of the vaccine in the second quarter of 2021.

Statistics:

  • The US government has agreements with five or six manufacturers for around 100 million doses.
  • 100 million doses of Pfizer's vaccine have been ordered, enough for 50 million people.
  • 200 million doses of Pfizer and BioNTech's vaccine will be acquired by the EU.
  • The first doses of Pfizer's COVID-19 vaccine were administered in the UK in December 2020.
  • Pfizer's COVID-19 vaccine is 95% effective.

Sources:

  • https://twitter.com/SquawkCNBC/status/1336305253021528064
  • https://www.businessinsider.com/trump-administration-rejected-pfizer-offer-more-covid-19-vaccine-doses-2020-12
  • https://www.nytimes.com/live/2020/12/07/world/covid-19-coronavirus/trump-administration-officials-passed-when-pfizer-offered-in-late-summer-to-sell-the-us-more-vaccine-doses
  • https://www.businessinsider.com/operation-warp-speed-heres-how-covid-19-vaccines-were-selected-2020-8
  • https://www.businessinsider.com/pfizer-biontech-seek-clearance-for-covid-19-vaccine-in-europe-2020-12
  • https://www.wsj.com/articles/pfizer-biontech-file-for-covid-19-vaccine-approval-in-europe-11606816904
  • https://www.businessinsider.com/us-turned-down-pfizers-offers-for-additional-covid-19-vaccines-2020-12

Read more